United States Senate Health Committee passed a bill aimed at decimalizing use of psychedelics drugs authorized by the Senator of San Francisco Scott Weiner. The committee voted 6:1 in favor of the psychedelics bill.
Senator Weiner introduced the Senate Bill 519 back in February, the bill is seeking to decriminalize the possession and personal use of certain psychedelic drugs. The bill is now set for the Senate Appropriations Committee.
Senatr Weiner claims that various recently studies by top medical universities show that ‘substances including psilocybin, psilocyn, methylenedioxymethamphetamine (“MDMA”), Lysergic acid diethylamide (“LSD”), ketamine, Dimethyltryptamine (“DMT”), mescaline (excluding peyote), and ibogaine, can have significant benefits for treating mental health and substance use disorders.’
In addition, the bill also erases all criminal record for all individuals convicted for possession or personal use of psychedelics substances.
It also advocates for a formation of a commission do deliver recommendations to the legislature regarding measures which can be put in place to control specified personal use of psychedelics in the future.